182 related articles for article (PubMed ID: 22261915)
1. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis.
Li R; Liu J; Xue H; Huang G
Int J Cancer; 2012 Oct; 131(8):1837-45. PubMed ID: 22261915
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and bivariate/HSROC random-effect meta-analysis of immunochemical and guaiac-based fecal occult blood tests for colorectal cancer screening.
Launois R; Le Moine JG; Uzzan B; Fiestas Navarrete LI; Benamouzig R
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):978-89. PubMed ID: 25072382
[TBL] [Abstract][Full Text] [Related]
3. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Meklin J; SyrjÄnen K; Eskelinen M
Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
[TBL] [Abstract][Full Text] [Related]
4. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study.
Shastri YM; Loitsch S; Hoepffner N; Povse N; Hanisch E; Rösch W; Mössner J; Stein JM
Am J Gastroenterol; 2008 Jun; 103(6):1496-504. PubMed ID: 18510609
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
[TBL] [Abstract][Full Text] [Related]
6. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.
Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC
Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis.
Zhu MM; Xu XT; Nie F; Tong JL; Xiao SD; Ran ZH
J Dig Dis; 2010 Jun; 11(3):148-60. PubMed ID: 20579218
[TBL] [Abstract][Full Text] [Related]
8. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test.
Kim YC; Kim JH; Cheung DY; Kim TH; Jun EJ; Oh JW; Kim CW; Chung WC; Kim BW; Kim SS; Kim JI; Park SH; Kim JK
Gut Liver; 2015 Sep; 9(5):641-8. PubMed ID: 25473070
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
[TBL] [Abstract][Full Text] [Related]
10. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.
Tonus C; Sellinger M; Koss K; Neupert G
World J Gastroenterol; 2012 Aug; 18(30):4004-11. PubMed ID: 22912551
[TBL] [Abstract][Full Text] [Related]
11. Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick-Lewis D; Ali MU; Warren R; Kenny M; Sherifali D; Raina P
Clin Colorectal Cancer; 2016 Dec; 15(4):298-313. PubMed ID: 27133893
[TBL] [Abstract][Full Text] [Related]
12. The ColonView (CV) Quick Test for Fecal Occult Blood Shows Significantly Higher Diagnostic Accuracy in Detecting Distal than Proximal Colorectal Cancer.
Eskelinen M; Meklin J; Guimarães DP; Selander T; Tiusanen T; Syrjänen K; Eskelinen M
Anticancer Res; 2022 Apr; 42(4):1879-1891. PubMed ID: 35347006
[TBL] [Abstract][Full Text] [Related]
13. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
14. Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis.
Nasir Kansestani A; Zare ME; Tong Q; Zhang J
Sci Rep; 2022 Feb; 12(1):2623. PubMed ID: 35173276
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.
Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA
J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277
[TBL] [Abstract][Full Text] [Related]
16. Stool test for colorectal cancer screening--it's time to move!
Loitsch SM; Shastri Y; Stein J
Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
Caviglia GP; Cabianca L; Fagoonee S; Gili FM
Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
[TBL] [Abstract][Full Text] [Related]
18. Screening for colon cancer: A test for occult blood.
Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
[TBL] [Abstract][Full Text] [Related]
19. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012.
Redwood D; Provost E; Asay E; Roberts D; Haverkamp D; Perdue D; Bruce MG; Sacco F; Espey D
Prev Chronic Dis; 2014 Apr; 11():E56. PubMed ID: 24721216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
